10x Genomics to Present at the 37th Annual J.P. Morgan Healthcare Conference
PLEASANTON, CA.—December 26, 2018—10x Genomics a leader in the genomics field, today announced the company will be participating in the upcoming 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
10x Genomics’ CEO, Serge Saxonov, is scheduled to present on Monday, January 7, 2019 at 9:00 a.m. Pacific Time.
About 10x Genomics
10x Genomics is committed to paving the way for a new understanding of biology, human health, and disease. The company was founded on the vision that this century will bring unprecedented advances in biomedicine to transform the way we treat diseases leading to dramatic improvements in human health. 10x products enable the acceleration of genetic discoveries through unparalleled resolution and are used in the Human Cell Atlas project as well as by leading biomedical research institutes, pharmaceutical companies, and clinical centers. Founded in 2012, 10x Genomics is financed by marquee global investors including Venrock, Softbank, Foresite Capital, Fidelity, and Meritech Capital. For more information, visit wp.10xgenomics.com.
Lizi Sprague, Consort Partners for 10x Genomics
Lynn Lewis or Carrie Mendivil